Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
1.835
+0.085 (4.86%)
Oct 20, 2026, 11:30 AM EDT - Market open

Pulmonx Revenue

Pulmonx had revenue of $22.76M in the quarter ending June 30, 2026, a decrease of -4.62%. This brings the company's total for the last twelve months to $87.44M, down -3.43% year-over-year. In the year 2025, Pulmonx had annual revenue of $90.50M with 8.01% growth. That makes Pulmonx the 23,676th largest company in the world by revenue and 3,380th in the United States.

Revenue (ttm)
$87.44M
Revenue Growth
-3.43%
P/S Ratio
0.86
Revenue / Employee
$295,412
Employees
296
Market Cap
78.81M

Revenue Chart

Revenue by Geography

  • United States 57.02M 63.0%
  • Europe, Middle-East and Africa (EMEA) 26.99M 29.8%
  • Asia Pacific 6.23M 6.9%
  • Other International 260.00K 0.3%
Fiscal year ended Dec 31, 2025 See the full Pulmonx breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202590.50M6.71M8.01%
Dec 31, 202483.79M15.11M22.01%
Dec 31, 202368.68M15.01M27.98%
Dec 31, 202253.66M5.25M10.84%
Dec 31, 202148.42M15.68M47.91%
Dec 31, 202032.73M138.00K0.42%
Dec 31, 201932.60M12.59M62.94%
Dec 31, 201820.00M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Outset Medical117.80M
LENSAR60.26M
Apyx Medical58.42M
Myomo43.26M
electroCore36.97M
Nyxoah24.75M
Hyperfine16.54M
Lucid Diagnostics5.45M
Revenue Rankings